E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Percutaneous support devices for high risk or complicated coronary angioplasty.
TL;DR: Percutaneous cardiopulmonary bypass provides complete systemic hemodynamic support which is independent of intrinsic cardiac function or rhythm and has been employed prophylactically in very high risk patients before coronary angioplasty or emergently for abrupt closure.
Journal ArticleDOI
Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
TL;DR: The incidence of central nervous system hemorrhage with tissue plasminogen activator is within the range reported with streptokinase, but because equal coronary artery thrombolytic doses are not known, no definitive comparison is possible.
Journal ArticleDOI
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.
L K Newby,Vic Hasselblad,Paul W. Armstrong,F. Van de Werf,Daniel B. Mark,Harvey D. White,Eric J. Topol,Robert M. Califf +7 more
TL;DR: Mixed-exponential survival modelling describes timing of post-infarction complications and supports discharge 4 days after uncomplicated infarction and could guide decision-making in other settings in which randomized studies are impractical.
Journal ArticleDOI
Using C-reactive protein to assess cardiovascular disease risk.
TL;DR: Whereas the guidelines suggest measuring the CRP level only in patients at intermediate risk, the advocates advocate measuring it as well in Patients at high risk.
Journal ArticleDOI
Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function.
TL;DR: In this article, a single nucleotide polymorphism (SNP), a proline (P387) rather than the predominant alanine (A387) at position 387 in thrombospondin-4 (TSP-4) and premature myocardial infarction was identified.